United States (US) Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
United States (US) Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Abstract
Summary
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The US biotechnology market had total revenues of $287.4 billion in 2021, representing a compound annual growth rate (CAGR) of 11.8% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $169.2 billion, equivalent to 58.9% of the market's overall value.
- The US market is by far the largest globally, accounting for 38.7% of its total value in 2021. Comparatively, the entire Asia-Pacific and European regions accounted for 33.6% and 21.3% of the global market’s value respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the United States biotechnology market by value in 2021?
- What will be the size of the United States biotechnology market in 2026?
- What factors are affecting the strength of competition in the United States biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in the United State's biotechnology market?
Content
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Do leading players have any notable weaknesses?
8 Company Profiles
8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: United States biotechnology industry value: $ billion, 2016–21
Table 2: United States biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: United States biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: United States biotechnology industry geography segmentation: $ billion, 2021
Table 5: United States biotechnology industry value forecast: $ billion, 2021–26
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: AbbVie Inc.: key facts
Table 11: AbbVie Inc.: Annual Financial Ratios
Table 12: AbbVie Inc.: Key Employees
Table 13: AbbVie Inc.: Key Employees Continued
Table 14: Amgen, Inc.: key facts
Table 15: Amgen, Inc.: Annual Financial Ratios
Table 16: Amgen, Inc.: Key Employees
Table 17: Amgen, Inc.: Key Employees Continued
Table 18: Biogen, Inc.: key facts
Table 19: Biogen, Inc.: Annual Financial Ratios
Table 20: Biogen, Inc.: Key Employees
Table 21: United States size of population (million), 2017–21
Table 22: United States gdp (constant 2005 prices, $ billion), 2017–21
Table 23: United States gdp (current prices, $ billion), 2017–21
Table 24: United States inflation, 2017–21
Table 25: United States consumer price index (absolute), 2017–21
Table 26: United States exchange rate, 2017–21
List of Figures
Figure 1: United States biotechnology industry value: $ billion, 2016–21
Figure 2: United States biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: United States biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2021
Summary
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The US biotechnology market had total revenues of $287.4 billion in 2021, representing a compound annual growth rate (CAGR) of 11.8% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $169.2 billion, equivalent to 58.9% of the market's overall value.
- The US market is by far the largest globally, accounting for 38.7% of its total value in 2021. Comparatively, the entire Asia-Pacific and European regions accounted for 33.6% and 21.3% of the global market’s value respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the United States biotechnology market by value in 2021?
- What will be the size of the United States biotechnology market in 2026?
- What factors are affecting the strength of competition in the United States biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in the United State's biotechnology market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Do leading players have any notable weaknesses?
8 Company Profiles
8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: United States biotechnology industry value: $ billion, 2016–21
Table 2: United States biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: United States biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: United States biotechnology industry geography segmentation: $ billion, 2021
Table 5: United States biotechnology industry value forecast: $ billion, 2021–26
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: AbbVie Inc.: key facts
Table 11: AbbVie Inc.: Annual Financial Ratios
Table 12: AbbVie Inc.: Key Employees
Table 13: AbbVie Inc.: Key Employees Continued
Table 14: Amgen, Inc.: key facts
Table 15: Amgen, Inc.: Annual Financial Ratios
Table 16: Amgen, Inc.: Key Employees
Table 17: Amgen, Inc.: Key Employees Continued
Table 18: Biogen, Inc.: key facts
Table 19: Biogen, Inc.: Annual Financial Ratios
Table 20: Biogen, Inc.: Key Employees
Table 21: United States size of population (million), 2017–21
Table 22: United States gdp (constant 2005 prices, $ billion), 2017–21
Table 23: United States gdp (current prices, $ billion), 2017–21
Table 24: United States inflation, 2017–21
Table 25: United States consumer price index (absolute), 2017–21
Table 26: United States exchange rate, 2017–21
List of Figures
Figure 1: United States biotechnology industry value: $ billion, 2016–21
Figure 2: United States biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: United States biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2021
Related Report
